https://www.selleckchem.com/pr....oducts/fen1-in-4.htm
All experienced acute toxicity that ultimately resolved 28.4% Grade 2 and 4.5% Grade 3. Larger treatment volume receiving ≥36Gy was associated with increased Grade ≥2 acute toxicity. Patients experienced late Grade 2 and late Grade 4 toxicity after 6.5% treatments each. Younger age was associated with increased Grade ≥2 late toxicity. "Good" or better cosmesis occurred in 93.2%, and "poor" cosmesis was associated with lower extremities and larger lesions. Hypofractionated HDR brachytherapy using 36Gy in six weekly fractions is associa
Like
Comment
Share
